284 related articles for article (PubMed ID: 34034648)
1. Factors influencing primary care physicians' prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study.
Chaterji S; Lian LG; Lee TY; Chua L; Wee SY; Yap SL; K DL; Tan NC
BMC Fam Pract; 2021 May; 22(1):101. PubMed ID: 34034648
[TBL] [Abstract][Full Text] [Related]
2. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey.
Carlin S; Bond A; Gross P; Bell A; Douketis J; Geerts W; Galanaud JP
Thromb Res; 2021 Jun; 202():176-181. PubMed ID: 33872825
[TBL] [Abstract][Full Text] [Related]
3. The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore.
Woo BFY; Lim TW; Tam WWS
Heart Lung Circ; 2019 Apr; 28(4):605-614. PubMed ID: 29705388
[TBL] [Abstract][Full Text] [Related]
4. A study of knowledge, attitudes, and practices of primary care physicians toward anticoagulant therapy in patients with non-valvular atrial fibrillation in Shanghai, China.
Ye S; Wang T; Liu A; Yu Y; Pan Z; Gu J
BMC Fam Pract; 2020 Aug; 21(1):165. PubMed ID: 32799797
[TBL] [Abstract][Full Text] [Related]
5. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
[TBL] [Abstract][Full Text] [Related]
6. A clinical audit of oral anticoagulant therapy in aged care residents with atrial fibrillation.
Bernaitis N; Bowden M; La Caze A
Int J Clin Pharm; 2020 Apr; 42(2):474-481. PubMed ID: 32291550
[TBL] [Abstract][Full Text] [Related]
7. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
[TBL] [Abstract][Full Text] [Related]
8. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
[TBL] [Abstract][Full Text] [Related]
9. Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.
Picard F; Ducrocq G; Danchin N; Falissard B; Hanon O; Mahe I; Touzé E; Steg PG
Arch Cardiovasc Dis; 2018 May; 111(5):349-356. PubMed ID: 29191525
[TBL] [Abstract][Full Text] [Related]
10. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
[TBL] [Abstract][Full Text] [Related]
11. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.
Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
J Clin Nurs; 2017 Dec; 26(23-24):4325-4334. PubMed ID: 28178370
[TBL] [Abstract][Full Text] [Related]
12. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
13. Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
Carnicelli AP; Hong H; Giugliano RP; Connolly SJ; Eikelboom J; Patel MR; Wallentin L; Morrow DA; Wojdyla D; Hua K; Hohnloser SH; Oldgren J; Ruff CT; Piccini JP; Lopes RD; Alexander JH; Granger CB;
Am Heart J; 2021 Mar; 233():48-58. PubMed ID: 33296688
[TBL] [Abstract][Full Text] [Related]
14. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
[TBL] [Abstract][Full Text] [Related]
15. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
[TBL] [Abstract][Full Text] [Related]
16. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
[TBL] [Abstract][Full Text] [Related]
17. Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.
Hua H; Sur N; Lee L; Chaturvedi S
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105474. PubMed ID: 33242786
[TBL] [Abstract][Full Text] [Related]
18. The Role Of NOACs in Atrial Fibrillation Management: A Qualitative Study.
Kirley K; GouthamRao ; Bauer V; Masi C
J Atr Fibrillation; 2016; 9(1):1416. PubMed ID: 27909516
[TBL] [Abstract][Full Text] [Related]
19. Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.
Kea B; Alligood T; Robinson C; Livingston J; Sun BC
Ann Emerg Med; 2019 Dec; 74(6):759-771. PubMed ID: 31080035
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
